User:Devonne Moore: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Blanked the page)
 
(15 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Amiodarone==
:Quick info on amiodarone, just what it is usually used for, maybe drug class and any black box warnings, regulatory status, brand and generic names
:May want to link out to foreign product names, if name is called something else in another country but patient is being treated here it could be a problem


===Indications===
:What the drug can be used for, may include off label here or it can have its own section
===Dosing Based on Indication===
:Dosing based on what it is being used for (including whether it is IV, oral, IM, SQ, etc
:Include renal dosing here?
===Available Preparations===
:What is commercially available and the route of administration
===Contraindications===
:What conditions should not be using the drug, including pregnant women and ped's
===Drug Interactions===
:Include the big ones at least, and how to compensate for them, whether it is reducing the dose/switching one of the meds etc
:include alcohol here
===Adverse Effects===
:Important to include common adverse events and serious ones to look out for
:Do we want to include how to mitigate events?
===Mechanism of Action===
:How the drug works, what receptors it effects,
===Pharmacokinetics===
:ADME of the drug
===Administration and Monitoring===
:What signs to look out for for therapeutic effect and toxic effect, including what labs to look at (esp imp for renal)
===Toxicity===
:What are the indications that the medication has reached toxic level, how to mitigate the effects (pH, dialysis, etc)
===Patient Information===
:Do we want a section for patients to look at? Less clinical, more to the point, more about what they can expect from the patient both positive and negative and when they need to contact physician. May include things that would usually go on auxilliary labels, things like drowsiness and photosensitivity.

Latest revision as of 11:48, 27 January 2012